ML13218A983

Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Part Two of the Application for Construction Permit

ML13218A983
Person / Time
Site:	SHINE Medical Technologies
Issue date:	08/16/2013
From:	Steven Lynch Research and Test Reactors Licensing Branch
To:	Bynum R SHINE Medical Technologies
Lynch S, 301-415-1524
Shared Package
ML13218B018	List: ML13218A983
References
TAC MF2307
Download: ML13218A983 (4)

Text

August 16, 2013 August XX, 2013 Richard Vann Bynum, Ph.D.

Chief Operating Officer SHINE Medical Technologies, Inc.

2555 Industrial Drive Monona, WI 53713

SUBJECT:

SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGEMENT OF RECEIPT OF PART TWO OF THE APPLICATION FOR CONSTRUCTION PERMIT (TAC NO. MF2307)

Dear Dr. Bynum:

By letter dated May 31, 2013 (SMT-2013-023, Agencywide Documents Access and Management System (ADAMS) Accession No. ML13172A361), SHINE Medical Technologies, Inc. (SHINE), submitted the second and final part of its two-part application for a construction permit, which if granted, would allow SHINE to construct a medical radioisotope production facility to be located in Janesville, Wisconsin.

Part one of SHINEs construction permit application was submitted by letter dated March 26, 2013 (ADAMS Accession No. ML13088A192). The U.S. Nuclear Regulatory Commission (NRC) staff acknowledged receipt of this partial application for a construction permit under Title 10 of the Code of Federal Regulations (10 CFR), Part 50 in the Federal Register (78 FR 29390) on May 20, 2013. An exemption from certain requirements of 10 CFR 2.101(a)(5) granted by the Commission on March 20, 2013 (ADAMS Accession No. ML13072B195), in response to a letter from SHINE dated February 18, 2013 (ADAMS Accession No. ML13051A007), allowed for SHINE to submit its construction permit application in two parts. Specifically, the exemption allowed SHINE to submit a portion of its application for a construction permit up to six months prior to the remainder of the application regardless of whether or not an environmental impact statement or a supplement to an environmental impact statement is prepared during the review of its application. In accordance with 10 CFR 2.101(a)(5), SHINE submitted the following in part one of its construction permit application:

the description and safety assessment of the site required by 10 CFR 50.34(a)(1) the environmental report required by 10 CFR 50.30(f) the filing fee information required by 10 CFR 50.30(e) and 10 CFR 170.21 the general information required by 10 CFR 50.33 the agreement limiting access to classified information required by 10 CFR 50.37

The NRC staff published in the Federal Register on July 1, 2013 (78 FR 39342), its determination that part one of SHINEs construction permit application is acceptable for docketing.

Part two of SHINEs application for a construction permit contains the remainder of the preliminary safety analysis report, as required by 10 CFR 50.34(a).

The NRC staff will review part two of SHINEs application for a construction permit and make a determination on the completeness and acceptability for docketing of the application. If the application is found acceptable, the staff will docket the application. Should the NRC staff determine that the application is incomplete and not acceptable for processing, SHINE will be informed of the ways in which the application is deficient.

Enclosed is the notice that will be forwarded to the Federal Register, informing the public of the receipt and availability of the subject application. To the extent possible, the NRC staff will communicate with SHINE any issues that arise during the acceptance review.

The staff intends to publish a review schedule for part one of SHINEs construction permit application following the completion of the acceptance review.

If you have any questions, please contact me at Steven.Lynch@nrc.gov or 301-415-1524.

Sincerely,

/RA/

Steven Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608

Enclosure:

Federal Register Notice cc: See next page

cc:

Jim Costedio Licensing Manager SHINE Medical Technologies, Inc.

2555 Industrial Drive Monona, WI 53713 Cindy Atkins-Duffin, Ph.D.

Senior Policy Analyst Office of Science and Technology Policy Executive Office Building 1650 Pennsylvania Avenue Washington, D.C. 20503 Joan Dix National Nuclear Security Administration, NA-212 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Cheryl Rogers Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Amanda Cushman Environmental Analysis and Review Specialist State of Wisconsin Department of Natural Resources 3911 Fish Hatchery Road Fitchburg, WI 53711 TRTR Newsletter University of Florida Department of Nuclear Engineering Sciences 202 Nuclear Sciences Center Gainesville, FL 32611 Jacob Winzenz Acting City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548 Gerald and Muriel Bumgarner 1735 S Osborne Ave Janesville, WI 53546

Pkg: ML13218B018 Letter: ML13218A983, FRN: ML13218A984 Memo to ADM: ML13218A986 ADM-012 OFFICE NRR/DPR/PRLB/PM NRR/DPR/PRLB/LA OGC NAME SLynch PBlechman SPrice DATE 08/06/2013 08/07/2013 08/15/2013 OFFICE NRR/DPR/PRLB/BC NRR/PRLB/PM NAME AAdams SLynch DATE 08/16/2013 08/16/2013